Skip to content

Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore

Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07176130
Enrollment
200
Registered
2025-09-16
Start date
2025-08-19
Completion date
2025-10-30
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endophthalmitis, Intraocular Lymphoma, Masquerade Syndromes, Scleritis and Episcleritis, Uveitis

Keywords

Uveitis, Scleritis, Masquerades syndromes, Intraocular lymphoma, Endophthalmitis

Brief summary

This is a retrospective study analyzing demographics, clinical characteristics, treatment received, and outcomes of ocular inflammatory diseases that presented to the Singapore National Eye Centre (SNEC).

Detailed description

This is a retrospective, cross-sectional study. In this study, the investigators aim to investigate demographics, clinical characteristics, treatment received, and outcomes of ocular inflammatory diseases, including masquerade syndromes such as ocular neoplasms (e.g., vitreoretinal and uveal lymphoma) and endophthalmitis that presented to the Singapore National Eye Centre (SNEC). Data on demographics, clinical features, diagnosis, investigations, secondary complications, treatment received, and outcomes will be analyzed using statistical software. The results of this study will lead to an improved clinical practice with better treatment selections and an optimized monitoring protocol for follow-up care for patients with ocular inflammatory diseases, including masquerade syndromes such as ocular neoplasms (e.g.,vitreoretinal and uveal lymphoma) and endophthalmitis. This will lead to better clinical outcomes and prevention of serious sight-threatening complications.

Interventions

OTHERNo Intervention: Observational Cohort

Not applicable, No intervention. Observational study.

Sponsors

Singapore National Eye Centre
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with uveitis * Patients diagnosed with scleritis or episcleritis * Patients diagnosed with ocular neoplasms e.g., vitreoretinal and uveal lymphoma * Patients diagnosed with endophthalmitis * Diagnosis confirmed by laboratory testing or histopathological examination * Patients diagnosed and managed at the Singapore National Eye Centre (SNEC)

Exclusion criteria

* Patients with less than two years of clinical follow-up * Patients with incomplete diagnostic confirmation (i.e., lacking laboratory or histopathological evidence) * Patients diagnosed outside of Singapore National Eye Centre (SNEC) * Cases with missing key clinical or outcome data

Design outcomes

Primary

MeasureTime frameDescription
Distribution of demographics, diagnosis, clinical features, treatment and outcomesJanuary 1987 and January 2025Percentage ethnic distribution, percentage of gender distribution, percentage of age distribution, percentage of etiology, percentage of clinical features, percentage of investigations, percentage of diagnosis, percentage of secondary complications, percentage of treatment received, percentage of outcomes

Secondary

MeasureTime frameDescription
Correlation of demographics, diagnosis, clinical features, and treatment outcomesJanuary 1987 and January 2025To evaluate the independent and combined effects of demographic factors, diagnostic categories, and clinical features on treatment outcomes using multivariate logistic and cox regression analysis

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026